B
Betsy C. Herold
Researcher at University of Chicago
Publications - 17
Citations - 2025
Betsy C. Herold is an academic researcher from University of Chicago. The author has contributed to research in topics: Virus & Herpes simplex virus. The author has an hindex of 10, co-authored 17 publications receiving 1980 citations. Previous affiliations of Betsy C. Herold include University of Illinois at Chicago & University of Iowa.
Papers
More filters
Journal ArticleDOI
Community-acquired methicillin-resistant staphylococcus aureus in children with no identified predisposing risk
Betsy C. Herold,Lilly Cheng Immergluck,Lilly Cheng Immergluck,Melinda C. Maranan,Diane S. Lauderdale,Ryan E. Gaskin,Susan Boyle-Vavra,Cindy D. Leitch,Robert S. Daum +8 more
TL;DR: It is demonstrated that the prevalence of community-acquired MRSA among children without identified risk factors is increasing, and the spectrum of disease associated with MRSA isolation is defined.
Journal ArticleDOI
Differences in the susceptibility of herpes simplex virus types 1 and 2 to modified heparin compounds suggest serotype differences in viral entry.
TL;DR: Using a series of intertypic recombinant mutant viruses, it is found that susceptibility to O-desulfated heparins can be transferred to HSV-1 by the gene for glycoprotein C ofHSV-2 (gC-2), which supports the notion that the envelope glycoproteins of HSv-1 and HSV -2 interact with different affinities for different structural features of heparin.
Journal ArticleDOI
Differences in the Role of Glycoprotein C of HSV-1 and HSV-2 in Viral Binding May Contribute to Serotype Differences in Cell Tropism
TL;DR: Results suggest that, in contrast to HSV-1, gC-2 does not play the key role in viral binding, and speculate that serotype differences in the contribution of gC to viral binding may contribute to serotypes differences in cell tropism.
Journal ArticleDOI
Identification of structural features of heparin required for inhibition of herpes simplex virus type 1 binding.
Betsy C. Herold,Susan I. Gerber,Tamar S. Polonsky,Brian J. Belval,Patrick N. Shaklee,Kevin R. Holme +5 more
TL;DR: This work compared the effects of modified heparin compounds on the binding and subsequent plaque formation of wild-type and gC-negative strains of HSV-1 and, in select cases, the binding of gB-negative virus to cells to suggest that gC and gB interact with different structural features of HS.
Journal ArticleDOI
Sulfated carbohydrate compounds prevent microbial adherence by sexually transmitted disease pathogens
Betsy C. Herold,Alicia M. Siston,James W. Bremer,Risa Kirkpatrick,George Wilbanks,Peter Fugedi,Csaba Peto,Morris Cooper +7 more
TL;DR: Using primary human culture systems, sulfated carbohydrate compounds that resemble HS and competitively inhibit infection by these pathogens are identified and are candidates for intravaginal formulations for the prevention of sexually transmitted diseases.